Accueil   Diary - News   All news Novadiscovery welcomes two new members to its team...

Novadiscovery welcomes two new members to its team…

to strengthen its combined expertise in artificial intelligence
and clinical medicine


  • David duVerle, PhD, previously academic researcher in computational biology and bioinformatics in Tokyo, Japan, notably at the University of Tokyo, becomes Chief Scientific Officer of the company
  • Professor Marc Hommel, neurologist at CHU Grenoble and professor at the faculty of medicine Grenoble Alps, is appointed as Vice President of Medicine of NOVADISCOVERY



 NOVADISCOVERY, a pioneer in in silico clinical trials, today announced the strengthening of its team with the nomination of its new Chief Scientific Officer, David duVerle, and the appointment of Prof. Marc Hommel as VP of Medicine.

These two arrivals are critical and in line with NOVA’s strategy of conjugating mechanistic (top-down) and data-heavy (bottom-up) approaches to perfect the use of AI and machine learning in drug research and development.



Read the press release